Formation of amyloid fibrils in vitro from partially unfolded intermediates of Human γC-crystallin

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 2, 2010, Pages 672-678

  Wang, Yongting ^a,b   Petty, Sarah ^c   Trojanowski, Amy ^c   Knee, Kelly ^b   Goulet, Daniel ^b   Mukerji, Ishita ^d   King, Jonathan ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c Department of Biology   (United States)

^d WESLEYAN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; GAMMA CRYSTALLIN; CRYGC PROTEIN, HUMAN; TRYPTOPHAN;

ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ESCHERICHIA COLI; FLUORESCENCE SPECTROSCOPY; HUMAN; INFRARED SPECTROSCOPY; MORPHOLOGY; PH; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN SECONDARY STRUCTURE; RAMAN SPECTROMETRY; TEMPERATURE; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROSCOPY; CHEMISTRY; GENETICS; PROTEIN FOLDING; SPECTROFLUOROMETRY; ULTRASTRUCTURE;

AMYLOID; ESCHERICHIA COLI; GAMMA-CRYSTALLINS; HUMANS; HYDROGEN-ION CONCENTRATION; MICROSCOPY, ELECTRON, TRANSMISSION; PROTEIN FOLDING; SPECTROMETRY, FLUORESCENCE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SPECTRUM ANALYSIS, RAMAN; TRYPTOPHAN;

EID: 77449100085     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-3987     Document Type: Article

References (39)

1. Harding JJ, Crabbe MJC. The lens: development, proteins, metabolism, and cataract. In: Dawson H, ed. The Eye. London: Academic Press; 1984:207-492.
2. Hanson SR, Hasan A, Smith DL, Smith JB. The major in vivo modifications of the human water-insoluble lens crystallins are disulfide bonds, deamidation, methionine oxidation and backbone cleavage. Exp Eye Res. 2000;71:195-207.
3. Horwitz J, Emmons T, Takemoto L. The ability of lens alpha crystallin to protect against heat-induced aggregation is age-dependent. Curr Eye Res. 1992;11:817-822.
4. Dobson CM. Protein folding and misfolding. Nature. 2003;426: 884-890.
5. Dobson CM. Principles of protein folding, misfolding and aggregation. Semin Cell Dev Biol. 2004;15:3-16.
6. Dobson CM. Protein aggregation and its consequences for human disease. Protein Pept Lett. 2006;13:219-227.
7. Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem. 2006;75:333-366.
8. Metlapally S, Costello MJ, Gilliland KO, et al. Analysis of nuclear fiber cell cytoplasmic texture in advanced cataractous lenses from Indian subjects using Debye-Bueche theory. Exp Eye Res. 2008;86: 434-444.
9. Kosinski-Collins MS, King J. In vitro unfolding, refolding, and polymerization of human γD crystallin, a protein involved in cataract formation. Protein Sci. 2003;12:480-490.
10. Colon W, Kelly JW. Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry. 1992;31: 8654-8660.
11. Meehan S, Berry Y, Luisi B, Dobson CM, Carver JA, MacPhee CE. Amyloid fibril formation by lens crystallin proteins and its implications for cataract formation. J Biol Chem. 2004;279:3413-3419.
12. Papanikolopoulou K, Mills-Henry I, Thol SL, et al. Formation of amyloid fibrils in vitro by human γD-crystallin and its isolated domains. Mol Vis. 2008;14:81-89.
13. Sandilands A, Hutcheson AM, Long HA, et al. Altered aggregation properties of mutant gamma-crystallins cause inherited cataract. EMBO J. 2002;21:6005-6014.
14. Lampi KJ, Ma Z, Shih M, et al. Sequence analysis of betaA3, betaB3, and betaA4 crystallins completes the identification of the major proteins in young human lens. J Biol Chem. 1997;272:2268-2275.
15. Robinson NE, Lampi KJ, Speir JP, et al. Quantitative measurement of young human eye lens crystallins by direct injection Fourier transform ion cyclotron resonance mass spectrometry. Mol Vis. 2006;12:704-711.
16. Basak A, Bateman O, Slingsby C, et al. High-resolution X-ray crystal structures of human gammaD crystallin (1.25 A) and the R58H mutant (1.15 A) associated with aculeiform cataract. J Mol Biol. 2003;328:1137-1147.
17. Kosinski-Collins MS, Flaugh SL, King J. Probing folding and fluorescence quenching in human gammaD crystallin Greek key domains using triple tryptophan mutant proteins. Protein Sci. 2004; 13:2223-2235.
18. Bassnett S. On the mechanism of organelle degradation in the vertebrate lens. Exp Eye Res. 2009;88:133-139.
19. Counis MF, Chaudun E, Arruti C, et al. Analysis of nuclear degradation during lens cell differentiation. Cell Death Differ. 1998;5: 251-261.
20. Smetana H. The relation of the reticulo-endothelial system to the formation of amyloid. J Exp Med. 1927;45:619-632.
21. Fu L, Liang JJ. Spectroscopic analysis of lens recombinant betaB2-and gammaC-crystallin. Mol Vis. 2001;7:178-183.
22. Knee KM, Roden CK, Flory MR, Mukerji I. The role of beta93 Cys in the inhibition of Hb S fiber formation. Biophys Chem. 2007; 127:181-193.
23. LeVine H 3rd. Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 1999;309:274-284.
24. Chen J, Flaugh SL, Callis PR, King J. Mechanism of the highly efficient quenching of tryptophan fluorescence in human gammaD-crystallin. Biochemistry. 2006;45:11552-11563.
25. Chen J, Toptygin D, Brand L, King J. Mechanism of the efficient tryptophan fluorescence quenching in human gammaD-crystallin studied by time-resolved fluorescence. Biochemistry. 2008;47: 10705-10721.
26. Chen J, Callis PR, King J. Mechanism of the very efficient quenching of tryptophan fluorescence in human gamma D-and gamma S-crystallins: the gamma-crystallin fold may have evolved to protect tryptophan residues from ultraviolet photodamage. Biochemistry. 2009;48:3708-3716.
27. Miura T, Takeuchi H, Harada I. Tryptophan Raman bands sensitive to hydrogen bonding and side-chain conformation. J Raman Spectrosc. 1989;20:667-671.
28. Bloemendal H, de Jong W, Jaenicke R, Lubsen NH, Slingsby C, Tardieu A. Ageing and vision: structure, stability and function of lens crystallins. Prog Biophys Mol Biol. 2004;86:407-485.
29. Austin JC, Jordan T, Spiro TG. Ultraviolet resonance Raman studies of proteins and related model compounds. In: Clark RJH, Hester RE, eds. Biomolecular Spectroscopy. New York, NY: John Wiley & Sons Ltd.; 1993.
30. Miura T, Takeuchi H, Harada I. Raman spectroscopic characterization of tryptophan side chains in lysozyme bound to inhibitors: role of the hydrophobic box in the enzymatic function. Biochemistry. 1991;30:6074-6080.
31. Naiki H, Higuchi K, Hosokawa M, Takeda T. Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. Anal Biochem. 1989;177:244-249.
32. Smith KF, Haris PI, Chapman D, Reid KBM, Perkins SJ. β-Sheet secondary structure of the trimeric globular domain of C1q of complement and collagen types VIII and X by Fourier-transform infrared spectroscopy and averaged structure predictions. Biochem J. 1994;301:249-256.
33. Byler DM, Susi H. Examination of the secondary structure of proteins by deconvolved FTIR spectra. Biopolymers. 1986;25: 469-487.
34. Zurdo J, Guijarro I, Dobson CM. Preparation and characterization of purified amyloid fibrils. J Am Chem Soc. 2001;123:8141-8142.
35. Nicholson EM, Mo H, Prusiner SB, Cohen FE, Marqusee S. Differences between the prion protein and its homolog Doppel: a partially structured state with implications for scrapie formation. J Mol Biol. 2002;316:807-815.
36. Wetzel R. Mutations and off-pathway aggregation of proteins. Trends Biotechnol. 1994;12:193-198.
37. Dobson CM. Getting out of shape. Nature. 2002;418:729-730.
38. Mitraki A, King J. Protein folding intermediates and inclusion body formation. BioTechnology. 1989;7:690-697.
39. Purkiss AG, Bateman OA, Wyatt K, et al. Biophysical properties of γC-crystallin in human and mouse eye lens: the role of molecular dipoles. J Mol Biol. 2007;372:205-222.